
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
American Well's Jeff Kosowsky, senior vice president, corporate development, discusses telehealth technology infrastructure, solutions, and health-system empowerment.
American Well's Jeff Kosowsky, senior vice president, corporate development, discusses telehealth technology infrastructure, solutions, and health-system empowerment.






